Myostatin Deficiency Protects C2C12 Cells from Oxidative Stress by Inhibiting Intrinsic Activation of Apoptosis

Cells. 2021 Jul 3;10(7):1680. doi: 10.3390/cells10071680.

Abstract

Ischemia reperfusion (IR) injury remains an important topic in clinical medicine. While a multitude of prophylactic and therapeutic strategies have been proposed, recent studies have illuminated protective effects of myostatin inhibition. This study aims to elaborate on the intracellular pathways involved in myostatin signaling and to explore key proteins that convey protective effects in IR injury. We used CRISPR/Cas9 gene editing to introduce a myostatin (Mstn) deletion into a C2C12 cell line. In subsequent experiments, we evaluated overall cell death, activation of apoptotic pathways, ROS generation, lipid peroxidation, intracellular signaling via mitogen-activated protein kinases (MAPKs), cell migration, and cell proliferation under hypoxic conditions followed by reoxygenation to simulate an IR situation in vitro (hypoxia reoxygenation). It was found that mitogen-activated protein kinase kinase 3/6, also known as MAPK/ERK Kinase 3/6 (MEK3/6), and subsequent p38 MAPK activation were blunted in C2C12-Mstn-/- cells in response to hypoxia reoxygenation (HR). Similarly, c-Jun N-terminal kinase (JNK) activation was negated. We also found the intrinsic activation of apoptosis to be more important in comparison with the extrinsic activation. Additionally, intercepting myostatin signaling mitigated apoptosis activation. Ultimately, this research validated protective effects of myostatin inhibition in HR and identified potential mediators worth further investigation. Intercepting myostatin signaling did not inhibit ROS generation overall but mitigated cellular injury. In particular, intrinsic activation of apoptosis origination from mitochondria was alleviated. This was presumably mediated by decreased activation of p38 caused by the diminished kinase activity increase of MEK3/6. Overall, this work provides important insights into HR signaling in C2C12-Mstn-/- cells and could serve as basis for further research.

Keywords: GDF8; hypoxia; ischemia; muscle; myostatin; reoxygenation; reperfusion; skeletal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldehydes / metabolism
  • Animals
  • Apoptosis*
  • Cell Hypoxia
  • Cell Line
  • Cell Movement
  • Cell Proliferation
  • Cytoprotection*
  • DNA Replication
  • Lipid Peroxidation
  • MAP Kinase Kinase 3 / metabolism
  • MAP Kinase Kinase 6 / metabolism
  • Mice
  • Myostatin / deficiency*
  • Myostatin / metabolism
  • Nitrosative Stress
  • Oxidative Stress*
  • Oxygen
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Aldehydes
  • Myostatin
  • Reactive Oxygen Species
  • 3-nitrotyrosine
  • Tyrosine
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 3
  • MAP Kinase Kinase 6
  • 4-hydroxy-2-nonenal
  • Oxygen